Dermal Cell News 2.20 June 6, 2016 | |
![]() | |
| |
TOP STORYARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma The authors showed that the small GTPase ARF6 acts as a proximal node of oncogenic Gαq signaling to induce all of these downstream pathways as well as β-catenin signaling. [Cancer Cell] Abstract | Graphical Abstract | |
![]()
| |
PUBLICATIONS(Ranked by impact factor of the journal)DERMAL STEM CELLS & TISSUE REGENERATIONScientists identified cooperative non-cell-autonomous functions of one and the same gene as a novel mechanism of tumor suppression in basal keratinocytes of zebrafish embryos. [eLife] Abstract | Download Full Article Researchers hypothesized that dermatological use of mineralocorticoid receptor antagonists may be beneficial by overcoming the negative impact of glucocorticoids treatment on pathological wounds. [J Invest Dermatol] Abstract Bilayer Cryogel Wound Dressing and Skin Regeneration Grafts for the Treatment of Acute Skin Wounds The potential of cryogel bilayer wound dressings and skin regenerating grafts for the treatment of surgically created full thickness wounds were evaluated. [ACS Appl Mater Interfaces] Abstract To study the function of laminin γ1 containing isoforms in skin development and maturation after birth, researchers generated mice lacking LAMC1 expression in basal keratinocytes using the keratin Cre/loxP system. [Matrix Biol] Abstract Investigators found that miR-1908 expression was inversely associated with the scar suppressor Ski in normal, burn-wounded, healing and scar dermal tissues in humans. [Cell Tissue Res] Abstract Heat-Mediated Reduction of Apoptosis in UVB-Damaged Keratinocytes In Vitro and in Human Skin Ex Vivo Using ex vivo skin models and primary keratinocytes in vitro, researchers showed that UVB plus heat treated keratinocytes exhibit persistent DNA damage, as observed with UVB alone. [BMC Dermatol] Full Article SKIN CANCERS & DISORDERSInvestigators recently implicated Caveolin-1 (CAV1) phosphorylation on tyrosine 14 in CAV1-enhanced cell migration. The contribution of this modification to the dual role of CAV1 in cancer remained unexplored. They used in vitro (2D and transendothelial cell migration, invasion) and in vivo (metastasis) assays, as well as genetic and biochemical approaches to address this question in B16F10 murine melanoma cells. [Oncotarget] Full Article Researchers verified the expression of miR-211 in melanoma cell lines and observed that its downregulation is associated with increased DNMT1 expression. [Biochem Biophys Res Commun] Abstract Pigment Production Analysis in Human Melanoma Cells The authors describe methods to detect changes in melanogenesis in a human melanoma cell line, MNT-1, by analyzing pigment production by measuring the absorbance of melanin present by spectrophotometry, analyzing transcript expression of potent regulators of melanogenesis by quantitative reverse-transcription (RT)PCR, and analyzing protein expression of potent regulators of melanogenesis by Western blot. [Methods Mol Biol] Abstract | |
![]()
| |
REVIEWSScarless Wound Healing: Finding the Right Cells and Signals The authors discuss several recent studies that identify exciting approaches for diminishing scar formation. Particular attention will also be paid to the canonical Wnt/β-catenin signaling pathway, which plays an important role in both embryogenesis and tissue repair. [Cell Tissue Res] Abstract | Graphical Abstract Visit our reviews page to see a complete list of reviews in the dermal cell research field.
| |
INDUSTRY NEWSWPI Team Awarded Patent for Reprogramming Skin Cells Cell therapies for a range of serious conditions, including heart attacks, diabetes, and traumatic injuries, will be accelerated by research at Worcester Polytechnic Institute (WPI) that yielded a newly patented method of converting human skin cells into engines of wound healing and tissue regeneration. [Worcester Polytechnic Institute] Press Release Regeneron Pharmaceuticals, Inc. and Sanofi announced that a one-year Phase III study, known as LIBERTY AD CHRONOS, evaluating investigational dupilumab met its primary and key secondary endpoints. [Regeneron Pharmaceuticals, Inc.] Press Release | |
From our sponsor: Optimize your ALDHbr cell detection with tissue-specific ALDEFLUORâ„¢ protocols. Watch the video.
| |
EVENTSNEW Gordon Research Conference – Notch Signaling in Development, Regeneration & Disease Visit our events page to see a complete list of events in the dermal cell community.
| |
JOB OPPORTUNITIESNEW Research Scientist – Hair Biophysics (L’Oreal) Scientific Communications and Publishing Coordinator (STEMCELL Technologies Inc.) Postdoctoral Scientist – Skin Cancer and Aging Group (Cancer Research UK Manchester Institute) Associate Professor/Professor – Dermatology (The University of Texas MD Anderson Cancer Center) Scientist – Target Validation (Innate Pharma) Medical Science Liaison Associate – Skin Diseases (Biofrontera Inc.) Postdoctoral Fellow – Biology (California Institute for Biomedical Research) Postdoctoral Positions – Immunology, Cancer, and Stem Cells (University of Connecticut) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Dermal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|
Home Dermal Cell News Volume 2.20 | Jun 6 2016